Free Trial
OTCMKTS:ATBPF

Antibe Therapeutics (ATBPF) Stock Price, News & Analysis

Antibe Therapeutics logo
$0.22 0.00 (0.00%)
As of 04/16/2025

About Antibe Therapeutics Stock (OTCMKTS:ATBPF)

Key Stats

Today's Range
$0.22
$0.22
50-Day Range
$0.22
$0.22
52-Week Range
$0.11
$0.89
Volume
N/A
Average Volume
27,352 shs
Market Capitalization
$11.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATBPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATBPF Stock News Headlines

APLIF Appili Therapeutics Inc.
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
Antibe Announces Appointment of Receiver
Antibe Announces Appointment of Receiver
Antibe Provides Update on CCAA Proceedings
Antibe Announces TSX Delisting Review
See More Headlines

ATBPF Stock Analysis - Frequently Asked Questions

Antibe Therapeutics' stock was trading at $0.2156 on January 1st, 2025. Since then, ATBPF stock has increased by 0.0% and is now trading at $0.2156.

Antibe Therapeutics Inc. (OTCMKTS:ATBPF) released its quarterly earnings data on Monday, November, 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.02.

Shares of ATBPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/13/2023
Today
9/05/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ATBPF
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-56.48%
Return on Assets
-29.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.06
Quick Ratio
10.06

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.58 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
52,981,000
Free Float
48,238,000
Market Cap
$11.42 million
Optionable
Not Optionable
Beta
0.51

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:ATBPF) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners